Acute rejection after liver transplantation despite intragraft coating by interleukin-2 receptor-alpha with basiliximab

Transplant Proc. 2001 Feb-Mar;33(1-2):1071-3. doi: 10.1016/s0041-1345(00)02420-9.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Graft Rejection / immunology*
  • Graft Rejection / prevention & control
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Transplantation / immunology*
  • Receptors, Interleukin-2 / immunology*
  • Recombinant Fusion Proteins*

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Basiliximab